The latest price target for Cross Country Healthcare (NASDAQ:CCRN) was reported by Barrington Research on December 10, 2024. The analyst firm set a price target for $0.00 expecting CCRN to fall to within 12 months (a possible -100.00% downside). 11 analyst firms have reported ratings in the last year.

The latest analyst rating for Cross Country Healthcare (NASDAQ:CCRN) was provided by Barrington Research, and Cross Country Healthcare downgraded their market perform rating.

The last upgrade for Cross Country Healthcare Inc happened on January 27, 2022 when Jefferies raised their price target to $27. Jefferies previously had a hold for Cross Country Healthcare Inc.

The last downgrade for Cross Country Healthcare Inc happened on December 10, 2024 when Barrington Research changed their price target from N/A to N/A for Cross Country Healthcare Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cross Country Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cross Country Healthcare was filed on December 10, 2024 so you should expect the next rating to be made available sometime around December 10, 2025.

While ratings are subjective and will change, the latest Cross Country Healthcare (CCRN) rating was a downgraded with a price target of $0.00 to $0.00. The current price Cross Country Healthcare (CCRN) is trading at is $17.91, which is out of the analyst’s predicted range.